Pediatric Donor Management Goals in Use by US Organ Procurement Organizations.

Autor: Ream RS; 1 Division of Pediatric Critical Care, Department of Pediatrics, Saint Louis University, St Louis, MO, USA., Clark MG; 1 Division of Pediatric Critical Care, Department of Pediatrics, Saint Louis University, St Louis, MO, USA., Armbrecht ES; 2 Department of Internal Medicine, Center for Outcomes Research, Saint Louis University, St Louis, MO, USA.
Jazyk: angličtina
Zdroj: Progress in transplantation (Aliso Viejo, Calif.) [Prog Transplant] 2019 Jun; Vol. 29 (2), pp. 150-156. Date of Electronic Publication: 2019 Mar 07.
DOI: 10.1177/1526924819835835
Abstrakt: Introduction: A recent study of pediatric organ donation after the neurologic determination of death (DNDD) demonstrated an association between the use of donor management goals (DMGs) by organ procurement organizations (OPOs) and organ yield.
Objective: To describe the pediatric DMGs used by OPOs and any association between specific DMGs and organ yield.
Design: Query of US OPOs who utilized DMGs in the care of pediatric DNDD organ donors from 2010 to 2013.
Results: All 23 OPOs using DMGs for pediatric DNDD organ donors during the study period participated (100%). The OPOs pursued an average 9.6 goals (standard deviation: 3.9; range: 5-22) with 113 unique definitions that targeted 33 aspects of donor hemodynamics, gas exchange/mechanical ventilation, electrolytes/renal function, blood products, thermoregulation, and infection control. The DMGs used by >50% of OPOs included blood pressure, oxygenation (partial pressure of arterial oxygen (PaO 2 ), oxygen saturation of hemoglobin by pulse oximetry, or PaO 2 /fractional concentration of inspired oxygen [FiO 2 ] ratio), pH, central venous pressure, serum sodium, urine output, limitations on inotropic support, and serum glucose. There was no significant correlation between the number of DMGs pursued by OPOs and organ yield. There was a difference in the observed/expected organs transplanted in the 0- to 10-year age-group for OPOs that included serum creatinine among their DMGs ( P = .046).
Conclusions: The pediatric DMGs used by OPOs were generally measurable but diverse in definition and the number of goals pursued. There was no benefit in organ yield from larger DMG bundles. There may be a benefit in organ yield through the use of serum creatinine as a DMG in pediatric donors aged 0 to 10 years.
Databáze: MEDLINE
Externí odkaz: